Context Capital Management’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Context Capital Management’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,526	Closed	-$1K	–	444
2022 Q4	$1K	Hold	57,526	–	–	﹤0.01%	437
2022 Q3	$5K	Hold	57,526	–	–	﹤0.01%	515
2022 Q2	$5K	Hold	57,526	–	–	﹤0.01%	565
2022 Q1	$12K	Buy	+57,526	New	+$17.3K	﹤0.01%	636

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Context Capital Management's IBER.WS Position: Q1 2023 in Review

Context Capital Management sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 57,526 shares — an estimated $1K sold.

Context Capital Management first reported a position in IBER.WS in Q1 2022 and held it in 4 quarters. The position peaked at $12K in Q1 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Context Capital Management reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Context Capital Management sold 57,526 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1K.
Context Capital Management first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2022 and held it in 4 quarters.
Context Capital Management's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $12K in Q1 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.